SCHEMBL12901783

SCHEMBL12901783

Cc1cc(NCc2ccccn2)c(C(F)(F)F)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
VNN1 O95497 1/20 0.47
PTK2 Q05397 2/20 0.45
PTK2B Q14289 2/20 0.45
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 4/20 0.44
CYP2C19 P33261 4/20 0.44
CYP2C9 P11712 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPT P10636 2/20 0.44
CYP2D6 P10635 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
KCNH2 Q12809 2/20 0.44
IL1B P01584 1/20 0.43
ALDH1A1 P00352 3/20 0.43
TSHR P16473 1/20 0.43
PIP4K2C Q8TBX8 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1232930 0.84 NPC1 (0.50) NPC1RAB9AVNN1PTK2PTK2B
SCHEMBL12901791 0.82 USP1 (0.47) VNN1PTK2CYP1A2CYP3A4CYP2C19
SCHEMBL15722570 0.80 MAOA (0.50) NPC1RAB9AVNN1CYP1A2CYP3A4
SCHEMBL12901052 0.77 MEN1 (0.49) NPC1RAB9ACYP1A2CYP3A4CYP2C19
SCHEMBL12902114 0.74 PTK2 (0.47) PTK2PTK2BCYP3A4
SCHEMBL13181871 0.72 PTK2 (0.48) NPC1RAB9AVNN1PTK2PTK2B
SCHEMBL12901776 0.72 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19CYP2C9MAPT
SCHEMBL12900562 0.72 PTK2 (0.65) PTK2PTK2B
SCHEMBL3122347 0.71 MAOA (0.55) NPC1RAB9AVNN1PTK2PTK2B
SCHEMBL29846220 0.71 MAOA (0.68) NPC1RAB9ACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046121-A1 INHIBITORS OF FOCAL ADHESION KINASE THE SCRIPPS RESEARCH INSTITUTE (US) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046121-A1 INHIBITORS OF FOCAL ADHESION KINASE PTK2, CABLES1, TNK2 NPC1 4663/4885RAB9A 2475/4885VNN1 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.